Daniel Bradbury, Director at CASTLE BIOSCIENCES INC (CSTL), sold 9,457 shares at $29.41 ($276K) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Scheduled sale ($276k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.39 | 1,530 | $43K | 15.7% |
| 2 | $28.39 | 434 | $12K | 4.5% |
| 3 | $29.41 | 857 | $25K | 9.1% |
| 4 | $29.41 | 3,015 | $89K | 32.1% |
| 5 | $29.41 | 3,015 | $89K | 32.1% |
| 6 | $29.82 | 134 |
| $4K |
| 1.4% |
| 7 | $29.82 | 472 | $14K | 5.1% |
| Total | $29.22 avg | 9,457 | $276K | 100% |
| Filing → |
| CSTL | SELL | 2024-11-05 | $318K | — | Filing → |
| CSTL | SELL | 2024-10-09 | $337K | — | Filing → |
| CSTL | SELL | 2024-09-09 | $333K | — | Filing → |